Menu
GWAS Study

Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia.

Trinder M, Vikulova D, Pimstone S et al.

34906840 PubMed ID
GWAS Study Type
349222 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TM
Trinder M
VD
Vikulova D
PS
Pimstone S
MG
Mancini GBJ
BL
Brunham LR
Chapter II

Abstract

Summary of the research findings

Background and aims: Familial combined hyperlipidemia (FCHL) is one of the most common inherited lipid phenotypes, characterized by elevated plasma concentrations of apolipoprotein B-100 and triglycerides. The genetic inheritance of FCHL remains poorly understood. The goals of this study were to investigate the polygenetic architecture and cardiovascular risk associated with FCHL.

3,838 British ancestry cases, 345,384 British ancestry controls

Chapter III

Study Statistics

Key metrics and study information

349222
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.